Immunotherapy in MSS/pMMR Metastatic Colorectal Cancer – Insights from the KEYNOTE-651
Microsatellite stable (MSS)/mismatch repair-proficient (pMMR) colorectal cancer (CRC) accounts for the majority of CRC cases and generally respond poorly to immunotherapy alone. This mini-review integrates findings from the KEYNOTE-651 study with current knowledge of frontline immunotherapy in MSS/pMMR metastatic CRC and explores the implications for clinical practice and future research directions.
Authors
- Richard D. Kim (ORCID: https://orcid.org/0000-0002-8448-844X)
- Raymond Miao
Publication Details
- Journal
- Journal of Cancer Immunology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.33696/cancerimmunol.7.100
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00